EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL

Josselen Carina Ramírez-Chiquito, Vanessa Villegas-Ruíz iD, Isabel Medina-Vera iD, Itzel Sánchez-Cruz, Christian Lizette Frías-Soria, Marcela Concepción Caballero Palacios, Gabriela Antonio-Andrés iD, Alejandra Elizabeth Rubio-Portillo, Liliana Velasco-Hidalgo iD, Mario Perezpeña-Diazconti iD, Cesar Alejandro Galván-Diaz, Norma Candelaria López-Santiago und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Josselen Carina Ramírez-Chiquito und 13 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SEP-CONACYT, CONACYT-FOSISS, FPIS2024-INP-6405.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL) is a malignant neoplasm with the highest incidence in the pediatric population. Although the 5-year overall survival is greater than 85%, in emerging countries such as Mexico, the mortality rate is high. In Mexico, B-ALL is the most common type of childhood cancer; different characteristics suggest the presence of the disease; however, the prognosis is dependent on clinical and laboratory features, and no adverse prognostic molecular marker for B-ALL has yet been identified. The present research aimed to identify the prognostic value of HMMR expression in pediatric patients with B-ALL. The differential expression profile of B-ALL cells was determined via in silico analysis, and HMMR expression was subsequently measured via qRT–PCR and immunocytochemistry. The results were statistically analyzed via the ROUT test, Kolmogorov–Smirnov Z test, and Mann–Whitney U test. ROC curves and the Youden index were constructed, and Kaplan–Meier curves were plotted. We found that HMMR expression was increased in B-ALL patients (p < 0.0001). We observed that high expression was related to poor prognosis (p < 0.05). We observed that high expression was related to poor prognosis (p < 0.05). The increase in HMMR expression could be a potential early molecular prognostic marker and/or a new target in childhood B-ALL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansMaleFemalePrognosisChildChild, PreschoolBiomarkers, TumorAdolescentInfantKaplan-Meier EstimateMexicoExtracellular Matrix Proteins

Stichwörter der Autor:innen

B-ALLHMMRRHAMMleukemiaprognostic molecular marker

Substanzen

hyaluronan-mediated motility receptorHyaluronan ReceptorsBiomarkers, TumorExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Experimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
  • Postgraduate in Biological Sciences, Postgraduate Unit, Building D, 1st Floor, Postgraduate Circuit, University City, Coyoacán, Mexico City 04510, Mexico.
  • Research Methodology Department, National Institute of Pediatrics, Mexico City 04530, Mexico.
  • Molecular Pathology Laboratory, Department of Pathology, National Institute of Pediatrics, Mexico City 04530, Mexico.
  • Department of Pediatric Oncology, National Institute of Pediatrics, Mexico City 04530, Mexico.
  • Oncology Research Unit, Hospital Infantil de México, Federico Gómez, Mexico City 06720, Mexico.

ORCID-Profile: Vanessa Villegas-Ruíz, Isabel Medina-Vera, Gabriela Antonio-Andrés, Liliana Velasco-Hidalgo, Mario Perezpeña-Diazconti, Sergio Juárez-Méndez

Förderung

  • SEP-CONACYT
  • CONACYT-FOSISS
  • FPIS2024-INP-6405
  • SEP-CONACyT México
  • FOSISS
  • E022 Program of the Instituto Nacional de Pediatrίa

Zitieren

APA

Ramírez-Chiquito, J. C., Villegas-Ruíz, V., Medina-Vera, I., Sánchez-Cruz, I., Frías-Soria, C. L., Caballero Palacios, M. C., Antonio-Andrés, G., Rubio-Portillo, A. E., Velasco-Hidalgo, L., Perezpeña-Diazconti, M., Galván-Diaz, C. A., López-Santiago, N. C., Huerta-Yepez, S., & Juárez-Méndez, S. (2025). Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020744

Vancouver

Ramírez-Chiquito JC, Villegas-Ruíz V, Medina-Vera I, Sánchez-Cruz I, Frías-Soria CL, Caballero Palacios MC, et al. Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020744

BibTeX
@article{RamrezChiquito2025,
  author = {Ramírez-Chiquito, Josselen Carina and Villegas-Ruíz, Vanessa and Medina-Vera, Isabel and Sánchez-Cruz, Itzel and Frías-Soria, Christian Lizette and Caballero Palacios, Marcela Concepción and Antonio-Andrés, Gabriela and Rubio-Portillo, Alejandra Elizabeth and Velasco-Hidalgo, Liliana and Perezpeña-Diazconti, Mario and Galván-Diaz, Cesar Alejandro and López-Santiago, Norma Candelaria and Huerta-Yepez, Sara and Juárez-Méndez, Sergio},
  title = {Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020744}
}
Kostenlos starten →